Skip to main content
. 2022 Mar 15;40(12):1681–1690. doi: 10.1016/j.vaccine.2021.10.062

Fig. 1.

Fig. 1

Timelines for the malaria vaccine RTS,S (Mosquirix) from concept to the point of consideration for global policy recommendation (over 35 years).

* Registered owner is GSK